Cargando…
Eligibility for PCSK9 Inhibitors According to American College of Cardiology (ACC) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) Guidelines After Acute Coronary Syndromes
BACKGROUND: The American College of Cardiology (ACC) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) have recently published recommendations for the use of proprotein convertase subtilisin/kexin‐9 (PCSK9) inhibitors in situations of very high risk. We aim to assess in t...
Autores principales: | Gencer, Baris, Koskinas, Konstantinos C., Räber, Lorenz, Karagiannis, Alexios, Nanchen, David, Auer, Reto, Carballo, David, Carballo, Sebastian, Klingenberg, Roland, Heg, Dik, Matter, Christian M., Lüscher, Thomas F., Rodondi, Nicolas, Mach, François, Windecker, Stephan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721754/ https://www.ncbi.nlm.nih.gov/pubmed/29122809 http://dx.doi.org/10.1161/JAHA.117.006537 |
Ejemplares similares
-
Cardiology on the cutting edge: updates from the European Society of Cardiology (ESC) Congress 2020
por: Gallego-Colon, Enrique, et al.
Publicado: (2020) -
Prognosis of cardiovascular and non-cardiovascular multimorbidity after acute coronary syndrome
por: Canivell, Silvia, et al.
Publicado: (2018) -
Summary of the 2007 European Society of Hypertension (ESH) and European Society of Cardiology (ESC) Guidelines for the Management of Arterial Hypertension
Publicado: (2007) -
European Society of Cardiology educational website
por: Sharma, Vinay K
Publicado: (2004) -
Clinical impact of a structured secondary cardiovascular prevention program following acute coronary syndromes: A prospective multicenter healthcare intervention
por: Carballo, David, et al.
Publicado: (2019)